糖尿病ペンの世界市場

◆英語タイトル:Global Diabetic Pens MARKET 2020-2024
◆商品コード:IRTNTR41174
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年2月13日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global Diabetic Pens Market 2020-2024Technavio has been monitoring the global diabetic pens market and it is poised to grow by USD 3.41 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on global diabetic pens market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diabetes.In addition, introduction of low-priced insulin injection pens is anticipated to boost the growth of the global diabetic pens market as well.
Market Segmentation
Technavio’s global diabetic pens market is segmented as below:
Product:
o Reusable Diabetic Pens

o Disposable Diabetic Pens

Geographic Segmentation:
o North America

o Europe

o Asia

o ROW

Key Trends for global diabetic pens market growth
This study identifies introduction of low-priced insulin injection pens as the prime reasons driving the global diabetic pens market growth during the next few years.
Prominent vendors in global diabetic pens market
We provide a detailed analysis of around 25 vendors operating in the global diabetic pens market, including some of the vendors such as AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pty. Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS and Sanofi .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/diabetic-pens-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

Executive Summary
o Market Overview
Market Landscape
o Market ecosystem
o Value chain analysis
Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
Market Segmentation by Product
o Market segments
o Comparison by Product placement
o Reusable diabetic pens – Market size and forecast 2019-2024
o Disposable diabetic pens – Market size and forecast 2019-2024
o Market opportunity by Product
Customer landscape
o Overview
Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher priced units
o Market challenges
o Market trends
Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Becton Dickinson and Co.
o Biocon Ltd.
o Companion Medical Inc.
o Digital Medics Pty. Ltd.
o Eli Lilly and Co.
o Emperra GmbH E-Health Technologies
o Jiangsu Delfu medical device Co. Ltd.
o Novo Nordisk AS
o Sanofi
Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
1.Key Finding 1
2.Key Finding 2
3.Key Finding 3
4.Key Finding 4
5.Key Finding 5
6.Key Finding 6
7.Key Finding 7
8.Market in focus
9.Parent market
10.Market characteristics
11.Product / Service portfolio of key vendors included in the market definition
12.Market segments
13.Global – Market size and forecast 2019 – 2024 ($ million)
14.Global market: Year-over-year growth 2019 – 2024 (%)
15.Five forces analysis 2019 & 2024
16.Bargaining power of buyers
17.Bargaining power of suppliers
18.Threat of new entrants
19.Threat of substitutes
20.Threat of rivalry
21.Market condition – Five forces 2019
22.Product placement – Market share 2019-2024 (%)
23.Comparison by Product placement
24.Reusable diabetic pens – Market size and forecast 2019-2024 ($ million)
25.Reusable diabetic pens – Year-over-year growth 2019-2024 (%)
26.Disposable diabetic pens – Market size and forecast 2019-2024 ($ million)
27.Disposable diabetic pens – Year-over-year growth 2019-2024 (%)
28. Market opportunity by Product
29.Customer landscape
30.Market share by geography 2019-2024 (%)
31.Geographic comparison
32.North America – Market size and forecast 2019-2024 ($ million)
33.North America – Year-over-year growth 2019-2024 (%)
34.Europe – Market size and forecast 2019-2024 ($ million)
35.Europe – Year-over-year growth 2019-2024 (%)
36.Asia – Market size and forecast 2019-2024 ($ million)
37.Asia – Year-over-year growth 2019-2024 (%)
38.ROW – Market size and forecast 2019-2024 ($ million)
39.ROW – Year-over-year growth 2019-2024 (%)
40.Key leading countries
41.Market opportunity by geography ($ million)
42.North America – Market size and forecast 2019-2024 ($ million)
43.North America – Year-over-year growth 2019-2024 (%)
44.Europe – Market size and forecast 2019-2024 ($ million)
45.Europe – Year-over-year growth 2019-2024 (%)
46.Asia – Market size and forecast 2019-2024 ($ million)
47.Asia – Year-over-year growth 2019-2024 (%)
48.ROW – Market size and forecast 2019-2024 ($ million)
49.ROW – Year-over-year growth 2019-2024 (%)
50.Impact of drivers
51.Impact of challenges
52.Landscape disruption
53.Industry risks
54.Vendors covered
55.Market positioning of vendors
56.AstraZeneca Plc – Overview (1/3)
57.AstraZeneca Plc – Overview (2/3)
58.AstraZeneca Plc – Overview (3/3)
59.AstraZeneca Plc – Business segments
60.AstraZeneca Plc – Key offerings
61.AstraZeneca Plc – Key customers
62.AstraZeneca Plc – Segment focus
63.Becton Dickinson and Co. – Overview (1/3)
64.Becton Dickinson and Co. – Overview (2/3)
65.Becton Dickinson and Co. – Overview (3/3)
66.Becton Dickinson and Co. – Business segments
67.Becton Dickinson and Co. – Key offerings
68.Becton Dickinson and Co. – Key customers
69.Becton Dickinson and Co. – Segment focus
70.Biocon Ltd. – Overview (1/3)
71.Biocon Ltd. – Overview (2/3)
72.Biocon Ltd. – Overview (3/3)
73.Biocon Ltd. – Business segments
74.Biocon Ltd. – Key offerings
75.Biocon Ltd. – Key customers
76.Biocon Ltd. – Segment focus
77.Companion Medical Inc. – Overview (1/3)
78.Companion Medical Inc. – Overview (2/3)
79.Companion Medical Inc. – Overview (3/3)
80.Companion Medical Inc. – Product and service
81.Companion Medical Inc. – Key offerings
82.Companion Medical Inc. – Key customers
83.Companion Medical Inc. – Segment focus
84.Digital Medics Pty. Ltd.  – Overview (1/3)
85.Digital Medics Pty. Ltd.  – Overview (2/3)
86.Digital Medics Pty. Ltd.  – Overview (3/3)
87.Digital Medics Pty. Ltd.  – Product and service
88.Digital Medics Pty. Ltd.  – Key offerings
89.Digital Medics Pty. Ltd.  – Key customers
90.Digital Medics Pty. Ltd.  – Segment focus
91.Eli Lilly and Co. – Overview (1/3)
92.Eli Lilly and Co. – Overview (2/3)
93.Eli Lilly and Co. – Overview (3/3)
94.Eli Lilly and Co. – Business segments
95.Eli Lilly and Co. – Key offerings
96.Eli Lilly and Co. – Key customers
97.Eli Lilly and Co. – Segment focus
98.Emperra GmbH E-Health Technologies – Overview (1/3)
99.Emperra GmbH E-Health Technologies – Overview (2/3)
100.Emperra GmbH E-Health Technologies – Overview (3/3)
101.Emperra GmbH E-Health Technologies – Product and service
102.Emperra GmbH E-Health Technologies – Key offerings
103.Emperra GmbH E-Health Technologies – Key customers
104.Emperra GmbH E-Health Technologies – Segment focus
105.Jiangsu Delfu medical device Co. Ltd. – Overview (1/3)
106.Jiangsu Delfu medical device Co. Ltd. – Overview (2/3)
107.Jiangsu Delfu medical device Co. Ltd. – Overview (3/3)
108.Jiangsu Delfu medical device Co. Ltd. – Product and service
109.Jiangsu Delfu medical device Co. Ltd. – Key offerings
110.Jiangsu Delfu medical device Co. Ltd. – Key customers
111.Jiangsu Delfu medical device Co. Ltd. – Segment focus
112.Novo Nordisk AS – Overview (1/3)
113.Novo Nordisk AS – Overview (2/3)
114.Novo Nordisk AS – Overview (3/3)
115.Novo Nordisk AS – Business segments
116.Novo Nordisk AS – Key offerings
117.Novo Nordisk AS – Key customers
118.Novo Nordisk AS – Segment focus
119.Sanofi – Overview (1/3)
120.Sanofi – Overview (2/3)
121.Sanofi – Overview (3/3)
122.Sanofi – Business segments
123.Sanofi – Key offerings
124.Sanofi – Key customers
125.Sanofi – Segment focus
126.Currency conversion rates for US$
127.Research Methodology
128.Validation techniques employed for market sizing
129.Information sources
130.List of abbreviations



【掲載企業】

AstraZeneca Plc,Becton Dickinson and Co.,Biocon Ltd.,Companion Medical Inc.,Digital Medics Pty. Ltd.,Eli Lilly and Co.,Emperra GmbH E-Health Technologies,Jiangsu Delfu medical device Co. Ltd.,Novo Nordisk AS,Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[糖尿病ペンの世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆